Ophthalmology News

Ophthal

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ganssauge M et al. – Risk of NA–AION should be taken into consideration when deciding for intravitreal application of drugs including anti–vascular endothelial growth factors (VEGF) agents like bevacizumab (Avastin) in the treatment of retinal vascular diseases.


Today in Clinical Pharmacology...keeping you current

Effect of oral azithromycin in the treatment of chlamydial conjunctivitis
Eye, 11/09/09

Central Corneal Thickness During Treatment With Travoprost 0.004% in Glaucoma Patients
Journal of Ocular Pharmacology and Therapeutics, 11/02/09

Retinal function in patients treated with tamoxifen
Documenta Ophthalmologica, 11/16/09

Today in Neuro-Ophthalmology...keeping you current

Surgical interventions for idiopathic intracranial hypertension
Current Opinion in Ophthalmology, 10/28/09

Headache and the eye
Current Opinion in Ophthalmology, 10/19/09

A retrospective study on the efficacy of total absorbed orbital doses of 12, 16 and 20 Gy combined with systemic steroid treatment in patients with Graves orbitopathy
Graefe's Archive for Clinical and Experimental Ophthalmology, 11/02/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address